Susquehanna Fundamental Investments, LLC Castle Biosciences Inc Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $154,529 - $256,410	8,547 New	8,547 $201,000
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $239,168 - $364,650	-10,625 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $69,657 - $98,658	-2,100 Reduced 16.5%	10,625 $477,000
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $205,260 - $355,132	-5,255 Reduced 29.23%	12,725 $546,000
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $1.08 Million - $1.4 Million	17,980 New	17,980 $1.2 Million

210

26.6M

128K

35.4K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $677M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.